© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
David P. Hudesman, shares insight on long-term extension data and clinical implications from ACG 2022 on the use of ustekinumab for the management of ulcerative colitis.
November 22nd 2022
David P. Hudesman, MD, provides insight on approaching induction therapy and maintenance therapy for patients with relapsing ulcerative colitis.
David P. Hudesman, MD, reviews data presented at the ACG 2022 Annual Scientific Meeting on the safety and efficacy of ustekinumab for ulcerative colitis treatment.
AMD Appeared More Common In Older, Female Patients at Rural Tertiary Care Hospital
Intravitreal Dexamethasone Implant Appeared Positive for Eyes with RVO-ME
Highly Aspherical Lenslet Spectacles Help Stop Progression of Myopia